Requip, Others Linked to Impulse Control Disorders
Written By: Rheingold, Giuffra, Ruffo & Plotkin LLP
A 2010
study of dopamine-replacement therapies and their link to impulse control disorders
(ICD) has shown that dopamine agonist therapies such as
Requip (Ropinirole)
in the treatment of Parkinson's Disease is associated with a
2 to 3.5 fold increase in odds of having an ICD.
Out of the 3090 patients studied 13.6% were identified as having an ICD (5% gambling addiction, 3.5% compulsive sexual behavior, 5.7% compulsive buying, 4.3% binge-eating disorder). 3.9% of those studied had 2 or more of these disorders.
A class action lawsuit has just been filed in Australia with over 100 people claiming damages after suffering the serious side effects of dopamine replacement therapies. If you have taken Requip (Ropinirole) and have developed an impulse control disorder that has ruined your life, Contact an experienced attorney at Rheingold, Giuffra, Ruffo & Plotkin LLP to speak with a lawyer.
Posted By
Rheingold, Giuffra, Ruffo & Plotkin LLP
Categories:
Out of the 3090 patients studied 13.6% were identified as having an ICD (5% gambling addiction, 3.5% compulsive sexual behavior, 5.7% compulsive buying, 4.3% binge-eating disorder). 3.9% of those studied had 2 or more of these disorders.
A class action lawsuit has just been filed in Australia with over 100 people claiming damages after suffering the serious side effects of dopamine replacement therapies. If you have taken Requip (Ropinirole) and have developed an impulse control disorder that has ruined your life, Contact an experienced attorney at Rheingold, Giuffra, Ruffo & Plotkin LLP to speak with a lawyer.